Oct 2, 2025 06:44AM

Aug 20, 2025 06:03AM

Jun 16, 2025 06:38AM

May 9, 2025 07:01AM

Mar 4, 2025 06:41AM

Nov 20, 2024 07:24AM

Oct 29, 2024 07:25AM H.C. Wainwright Reiterates Buy Rating on Celldex Therapeutics (CLDX)

Sep 26, 2024 06:28AM

Mar 5, 2024 10:10AM

Feb 29, 2024 09:15PM

Feb 29, 2024 09:14PM

Nov 8, 2023 05:57AM

Nov 7, 2023 11:15PM

Nov 6, 2023 10:10AM Celldex Therapeutics (CLDX) PT Raised to $80 at H.C. Wainwright

Mar 29, 2023 09:01AM

Jul 21, 2022 10:07AM

Sep 13, 2021 12:03PM

Jul 16, 2021 04:01PM

Jul 14, 2021 05:04AM

Jul 13, 2021 08:30PM

Jul 13, 2021 09:25AM Pre-Open Stock Movers 07/13: (DPW) (PLXP) (MSEX) Higher; (SLP) (TWO) (AFIB) Lower (more...)

Jul 12, 2021 10:18AM

Jul 12, 2021 06:21AM

Mar 5, 2021 01:00PM

Feb 23, 2021 07:10AM

Oct 19, 2020 06:24AM

Sep 10, 2020 04:01PM

Jun 18, 2020 10:31AM Celldex Therapeutics Announces Closing of $150.0 Million Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Jun 16, 2020 05:51AM

Jun 15, 2020 10:35PM

Mar 8, 2019 07:31AM

May 17, 2018 11:33AM

Apr 16, 2018 10:54AM

Mar 8, 2018 09:30AM

Aug 1, 2017 07:24AM UPDATE: H.C. Wainwright Assumes Celldex Therapeutics (CLDX) at Buy

Mar 15, 2017 08:27AM

20,596 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All